These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 9661019)

  • 1. Antiproliferative effects and mechanism of action of SCH 56592 against Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies.
    Urbina JA; Payares G; Contreras LM; Liendo A; Sanoja C; Molina J; Piras M; Piras R; Perez N; Wincker P; Loebenberg D
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1771-7. PubMed ID: 9661019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro antiproliferative effects and mechanism of action of the new triazole derivative UR-9825 against the protozoan parasite Trypanosoma (Schizotrypanum) cruzi.
    Urbina JA; Lira R; Visbal G; Bartrolí J
    Antimicrob Agents Chemother; 2000 Sep; 44(9):2498-502. PubMed ID: 10952601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiproliferative effects of delta 24(25) sterol methyl transferase inhibitors on Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies.
    Urbina JA; Vivas J; Lazardi K; Molina J; Payares G; Piras MM; Piras R
    Chemotherapy; 1996; 42(4):294-307. PubMed ID: 8804798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activities of the triazole derivative SCH 56592 (posaconazole) against drug-resistant strains of the protozoan parasite Trypanosoma (Schizotrypanum) cruzi in immunocompetent and immunosuppressed murine hosts.
    Molina J; Martins-Filho O; Brener Z; Romanha AJ; Loebenberg D; Urbina JA
    Antimicrob Agents Chemother; 2000 Jan; 44(1):150-5. PubMed ID: 10602737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro antiproliferative effects and mechanism of action of the bis-triazole D0870 and its S(-) enantiomer against Trypanosoma cruzi.
    Liendo A; Lazardi K; Urbina JA
    J Antimicrob Chemother; 1998 Feb; 41(2):197-205. PubMed ID: 9533461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mevinolin (lovastatin) potentiates the antiproliferative effects of ketoconazole and terbinafine against Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies.
    Urbina JA; Lazardi K; Marchan E; Visbal G; Aguirre T; Piras MM; Piras R; Maldonado RA; Payares G; de Souza W
    Antimicrob Agents Chemother; 1993 Mar; 37(3):580-91. PubMed ID: 8460926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental chemotherapy with combinations of ergosterol biosynthesis inhibitors in murine models of Chagas' disease.
    Maldonado RA; Molina J; Payares G; Urbina JA
    Antimicrob Agents Chemother; 1993 Jun; 37(6):1353-9. PubMed ID: 8328786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parasitological cure of acute and chronic experimental Chagas disease using the long-acting experimental triazole TAK-187. Activity against drug-resistant Trypanosoma cruzi strains.
    Urbina JA; Payares G; Sanoja C; Molina J; Lira R; Brener Z; Romanha AJ
    Int J Antimicrob Agents; 2003 Jan; 21(1):39-48. PubMed ID: 12507836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiproliferative effects and mechanism of action of ICI 195,739, a novel bis-triazole derivative, on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi.
    Urbina JA; Lazardi K; Aguirre T; Piras MM; Piras R
    Antimicrob Agents Chemother; 1991 Apr; 35(4):730-5. PubMed ID: 2069379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sterol composition and biosynthesis in Trypanosoma cruzi amastigotes.
    Liendo A; Visbal G; Piras MM; Piras R; Urbina JA
    Mol Biochem Parasitol; 1999 Oct; 104(1):81-91. PubMed ID: 10589983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cure of short- and long-term experimental Chagas' disease using D0870.
    Urbina JA; Payares G; Molina J; Sanoja C; Liendo A; Lazardi K; Piras MM; Piras R; Perez N; Wincker P; Ryley JF
    Science; 1996 Aug; 273(5277):969-71. PubMed ID: 8688084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ergosterol biosynthesis and drug development for Chagas disease.
    Urbina JA
    Mem Inst Oswaldo Cruz; 2009 Jul; 104 Suppl 1():311-8. PubMed ID: 19753490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo activities of ravuconazole on Trypanosoma cruzi, the causative agent of Chagas disease.
    Urbina JA; Payares G; Sanoja C; Lira R; Romanha AJ
    Int J Antimicrob Agents; 2003 Jan; 21(1):27-38. PubMed ID: 12507835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of the new triazole derivative albaconazole against Trypanosoma (Schizotrypanum) cruzi in dog hosts.
    Guedes PM; Urbina JA; de Lana M; Afonso LC; Veloso VM; Tafuri WL; Machado-Coelho GL; Chiari E; Bahia MT
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4286-92. PubMed ID: 15504854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo activity of the bis-triazole D0870 against drug-susceptible and drug-resistant strains of the protozoan parasite Trypanosoma cruzi.
    Molina J; Brener Z; Romanha AJ; Urbina JA
    J Antimicrob Chemother; 2000 Jul; 46(1):137-40. PubMed ID: 10882704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of the sterol composition of Trypanosoma (Schizotrypanum) cruzi epimastigotes by delta 24(25)-sterol methyl transferase inhibitors and their combinations with ketoconazole.
    Urbina JA; Vivas J; Visbal G; Contreras LM
    Mol Biochem Parasitol; 1995 Jul; 73(1-2):199-210. PubMed ID: 8577328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting calcium homeostasis as the therapy of Chagas' disease and leishmaniasis - a review.
    Benaim B; Garcia CR
    Trop Biomed; 2011 Dec; 28(3):471-81. PubMed ID: 22433874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy of Chagas' disease: the how and the why.
    Urbina JA
    J Mol Med (Berl); 1999 Mar; 77(3):332-8. PubMed ID: 10090596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Searching for new drugs for Chagas diseases: triazole analogs display high in vitro activity against Trypanosoma cruzi and low toxicity toward mammalian cells.
    Faria RX; Gonzaga DTG; Pacheco PAF; Souza ALA; Ferreira VF; da Silva FC
    J Bioenerg Biomembr; 2018 Apr; 50(2):81-91. PubMed ID: 29473131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective in vitro effects of the farnesyl pyrophosphate synthase inhibitor risedronate on Trypanosoma cruzi.
    Garzoni LR; Caldera A; Meirelles Mde N; de Castro SL; Docampo R; Meints GA; Oldfield E; Urbina JA
    Int J Antimicrob Agents; 2004 Mar; 23(3):273-85. PubMed ID: 15164969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.